KRYSTEXXA (also known as Pegloticase)
Krystexxa is an enzyme that breaks down uric acid, which otherwise accumulates in gout and precipitates, causing gout flares.
- Gout who have not responded to conventional therapy.
Patients with G6PD deficiency should not be started on Krystexxa. Patients with heart failure should consult their physicians before starting on Krystexxa.
Krystexxa is typically administered as an infusion every 2 weeks.